A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Virtual Rehabilitation in HCT
- Status
- RECRUITING
- Phase
- NA
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Status
- RECRUITING
- Phase
- N/A
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Topical Ruxolitinib Evaluation in Chronic Hand Eczema
- Status
- COMPLETED
- Phase
- PHASE2
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2